Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy

• Published in: International journal of chronic obstructive pulmonary disease 2018-01, Vol.13, p.2455
• Main Authors: Palmiotti, Giuseppe Antonio, Lacedonia, Donato, Liotino, Vito, Schino, Pietro, Satriano, Francesco, Di Napoli, Pier Luigi, Sabato, Eugenio, Mastrosimone, Vincenzo, Scoditti, Alfredo, Carone, Mauro, Costantino, Elio, Resta, Emanuela, Attolini, Ettore, Barbar, Maria Pia Foschino
• Format: Article
• Language: English
• Subjects: Ambulatory care facilities; Chronic obstructive lung disease; Corticosteroid drugs; Health aspects; Health care costs; Health care reform; Lung diseases; Medical economics; Steroids (Organic compounds)
• ISSN: 1178-2005
• DOI: 10.2l47/COPD.S157779

Background: COPD is a disease associated with significant economic burden. It was reported that Global initiative for chronic Obstructive Lung Disease (GOLD) guideline-oriented pharmacotherapy improves airflow limitation and reduces health care costs. However, several studies showed a significant dissociation between international recommendations and clinicians' practices. The consequent reduced diagnostic and therapeutic inappropriateness has proved to be associated with an increase in costs and a waste of economic resources in the health sector. The aim of the study was to evaluate COPD management in the Puglia region. The study was performed in collaboration with the pulmonology centers and the Regional Health Agency (AReS Puglia). Methods: An IT platform allowed the pulmonologists to enter data via the Internet. All COPD patients who visited a pneumological outpatient clinic for the first time or for regular follow-ups or were admitted to a pneumological department for an exacerbation were considered eligible for the study. COPD's diagnosis was confirmed by a pulmonologist at the moment of the visit. The project lasted 18 months and involved 17 centers located in the Puglia region. Results: Six hundred ninety-three patients were enrolled, evenly distributed throughout the region. The mean age was 71[+ or -]9 years, and 85% of them were males. Approximately 23% were current smokers, 63% former smokers and 13.5% never smokers. The mean post-bronchodilator forced expiratory volume in 1 second was 59%[+ or -]20% predicted. The platform allowed the classification of patients according to the GOLD guidelines (Group A: 20.6%, Group B: 32.3%, Group C: 5.9% and Group D: 39.2%), assessed the presence and severity of exacerbations (20% of the patients had an exacerbation defined as mild [13%], moderate [37%] and severe [49%]) and evaluated the appropriateness of inhalation therapy at the time of the visit. Forty-nine percent of Group A patients were following inappropriate therapy; in Group B, 45.8% were following a therapy in contrast with the guidelines. Among Group C patients, 41.46% resulted in triple combination therapy, while ~14% of Group D patients did not have a therapy or were following an inappropriate therapy. In conclusion, 30% of all patients evaluated had been following an inadequate therapy. Subsequently, an online survey was developed to inquire about the reasons for the results obtained. In particular, we investigated the reasons why 30% of our